Skip to main content
SpringerLink
Log in

Reliability of the diagnostic tests for Cushing’s syndrome performed in a tertiary referral center

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The study aimed to retrospectively evaluate the reliability of the diagnostic and location tests in Cushing’s Syndrome (CS). Eighty-seven patients diagnosed with CS between 1995 and 2007 by Endocrinology Metabolism Department of Cerrahpasa Medical School were included in the study. The control group consisted of 91 patients who presented to the outpatient clinic because of obesity. The diagnostic tests were as follows: 1 mg dexamethasone suppression test (DST), 24-h urinary free cortisol (UFC), midnight cortisol level (MCL), ACTH level and overnight 8 mg DST. The sensitivity and specificity of UFC were 81 and 66 % respectively for the cut-off point of 50 μg/day, whereas they were 64 and 76 % respectively for the cut-off point of 100 μg/day. For the cut-off value of 1.8/μg/dL for MCL and 1 mDST, the sensitivity rates were 100 and 98 %, while the specificity rates were 88 and 33 %, respectively. Among the location tests, the sensitivity and specificity of ACTH under 10 pg/mL for adrenal CS were 92 and 94 % respectively. The sensitivity and specificity of ACTH higher than 30 pg/mL for ACTH-dependent CS were 69 and 100 % respectively. The sensitivity rates of 8 mg DST for 50 and 60 % suppressions were 83 and 79 % respectively, whereas the specificity rates were 75 and 88 % respectively. 1 mg DST (cut-off <1.8 μg/dL) and UFC (50 μg/24 h) are appropriate tests for screening CS. Overnight 8 mg DST with 60 % suppression for Cushing’s Disease (CD) and ACTH levels <10 pg/mL for adrenal CS, ACTH levels >30 pg/mL for ACTH dependency were identified as the best tests for the differential diagnosis of the subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623

    Article  PubMed  CAS  Google Scholar 

  2. Cavagnini F, Pecori Giraldi F (2001) Epidemiology and follow-up of Cushing’s disease. Annales d’endocrinologie 62:168–172

    PubMed  CAS  Google Scholar 

  3. Nieman LK, Biller BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540

    Article  PubMed  CAS  Google Scholar 

  4. Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kasteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population base study. J Clin Endocrinol Metab 86:117–123

    Article  PubMed  CAS  Google Scholar 

  5. Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479–484

    Article  CAS  Google Scholar 

  6. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W (1992) Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75:826–832

    Article  PubMed  CAS  Google Scholar 

  7. Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P (2010) Screening for Cushing’s syndrome in obese patients. Clinics (Sao Paulo) 65(1):9–13

    Article  Google Scholar 

  8. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998–1003

    Article  PubMed  CAS  Google Scholar 

  9. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ (1996) Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol 44:717–722

    Article  CAS  Google Scholar 

  10. Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F (2003) Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 88:4153–4160

    Article  PubMed  CAS  Google Scholar 

  11. Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol 157:725–731

    Article  PubMed  CAS  Google Scholar 

  12. Reimondo G, Pia A, Bovio S, Allasino B, Daffara F, Paccotti P, Borretta G, Angeli A, Terzolo M (2008) Laboratory differentiation of Cushing’s syndrome. Clin Chim Acta 388:5–14

    Article  PubMed  CAS  Google Scholar 

  13. Mericq MV, Cutler GB Jr (1998) High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab 83:682–686

    Article  PubMed  CAS  Google Scholar 

  14. Cronin C, Igoe D, Duffy MJ, Cunningham SK, McKenna TJ (1990) The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol 3:27–33

    Article  Google Scholar 

  15. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome—recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34:222–223

    PubMed  CAS  Google Scholar 

  16. Nieman LK (2006) Difficulty in the diagnosis of Cushing disease. Nat Clin Pract Endocrinol Metab 2:53–57

    Article  PubMed  Google Scholar 

  17. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M (1995) A single sleeping midnight cortisol has 100 % sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43:545–550

    Article  CAS  Google Scholar 

  18. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F (2007) The dexamethasone-supressed corticotropin-releasing stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s state. Clin Endocrinol (Oxf) 66:251–257

    Article  Google Scholar 

  19. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19:647–672

    Article  PubMed  CAS  Google Scholar 

  20. Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s syndrome. Endocrinol Metab Clin N Am 37:135–149

    Article  CAS  Google Scholar 

  21. Pecori Giraldi F, Saccani A, Cavagnini F, The Study Group on the Hypothalamo-Pituitary—Adrenal Axis of the Italian Society of Endocrinology (2011) Assessment of ACTH assay variability: a multicenter study. Eur J Endocr 164:505–512

    Article  Google Scholar 

  22. Raff H, Findling JW (2003) A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 17:980–991

    Article  Google Scholar 

  23. Ilıas I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955–4962

    Article  PubMed  Google Scholar 

  24. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440–448

    Article  PubMed  CAS  Google Scholar 

  25. Vilar L, Freitas MC, Naves LA, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Arruda MJ, Silva LM, Arahata CM, Agra R, Lima LH, Azevedo M, Casulari LA (2008) The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome. J Endocrinol Invest 31(11):1008–1013

    PubMed  CAS  Google Scholar 

  26. Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamathasone suppression testing in the differential diagnosis of adrenocorticotropin—dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785

    Article  PubMed  CAS  Google Scholar 

  27. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422

    Article  PubMed  CAS  Google Scholar 

  28. Erem C, Algün E, Ozbey N, Azezli A, Aral F, Orhan Y, Molvalılar S, Sencer E (2003) Clinical laboratory findings and results of therapy in 55 patients with Cushing’s syndrome. J Endocrinol Invest 26:65–72

    PubMed  CAS  Google Scholar 

  29. Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of dynamic tests for ACTH-dependent Cushing’s syndrome. Endocr J 56(3):469–476

    Article  PubMed  CAS  Google Scholar 

  30. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88:299–306

    Article  Google Scholar 

Download references

Acknowledgments

This research did not receive any specific grant from any funding agencies in the public, commercial, or non-profit sector.

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey

    Mutlu Günes, Ozlem Celik & Pinar Kadioglu

  2. Cerrahpasa Tip Fakültesi, Ic Hastalıkları Anabilim Dali, Endokrinoloji-Metabolizma ve Diyabet Bilim Dali, 34303, Cerrahpasa, Istanbul, Turkey

    Pinar Kadioglu

Authors
  1. Mutlu Günes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozlem Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pinar Kadioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pinar Kadioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Günes, M., Celik, O. & Kadioglu, P. Reliability of the diagnostic tests for Cushing’s syndrome performed in a tertiary referral center. Pituitary 16, 139–145 (2013). https://doi.org/10.1007/s11102-012-0387-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-012-0387-7

Keywords

Search

Navigation